MANE Short Volume

Veradermics, Incorporated (MANE) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $4.18B, listed on NYSE, employing roughly 21 people, carrying a beta of 0.00 to the broader market. Veradermics, Incorporated operates as a biopharmaceutical company focused on developing novel therapeutics for dermatologic and aesthetic conditions. Led by Reid Waldman, public since 2026-02-04.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date

2026-06-01

Short Volume

120.7K

Total Volume

202.3K

Short %

59.68%

30-Day Avg Short %

68.75%

Showing 30 days of FINRA short volume data for Veradermics, Incorporated.

Learn how short volume is reported and how to read the data →

Frequently asked MANE short volume questions

What is the daily MANE short volume?

As of Jun 1, 2026, Veradermics, Incorporated (MANE) short volume is 120.7K shares against 202.3K total reported volume, or 59.68% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.

How is MANE short volume reported?

FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.

What does MANE short volume tell options traders?

Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.